You are using an outdated browser. Please upgrade your browser to improve your experience.

lutetium (177Lu) oxodotreotide

Ligand Summary
Lutetium Lu 177 dotatate binds to somatostatin receptors with highest affinity for subtype 2 receptors (SSTR2). Upon binding to somatostatin receptor expressing cells, including malignant somatostatin receptor-positive tumors, the compound is internalized. The beta emission from Lu 177 induces cellular damage by formation of free radicals in somatostatin receptor-positive cells and in neighboring cells.
Synonyms & Links
DrugCentral: 5275
LyCHI:  lutetium (177Lu) oxodotreotide